Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008825 |
---|---|
Receipt number | R000010349 |
Scientific Title | Phase II clinical trial of personalized peptide vaccination for patient with advanced head and neck cancer resistant to standard therapies . |
Date of disclosure of the study information | 2012/08/31 |
Last modified on | 2019/12/06 14:50:08 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/08/31 16:59:37 | ||
2 | Update | 2012/09/10 10:40:43 | Key inclusion criteria |
|
3 | Update | 2014/07/14 16:46:44 | Division name Division name Address Address TEL Institute Institute Organization Organization Category of Funding Organization |
|
4 | Update | 2014/12/12 12:10:07 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2019/01/07 11:05:36 | Recruitment status Anticipated trial start date |
|
6 | Update | 2019/12/06 14:50:08 | Recruitment status Date of IRB Last follow-up date |